Skip to main content
Veterinary Medicines

TENSOLVET GEL

Not authorised
  • HYDROXYETHYL SALICYLATE PH. EUR.
  • Levomenthol
  • Heparin sodium

Product identification

Medicine name:
TENSOLVET GEL
Active substance:
  • HYDROXYETHYL SALICYLATE PH. EUR.
  • Levomenthol
  • Heparin sodium
Target species:
  • Horse
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • HYDROXYETHYL SALICYLATE PH. EUR.
    50.00
    milligram(s)
    /
    1.00
    gram(s)
  • Levomenthol
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Heparin sodium
    50.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Gel
Withdrawal period by route of administration:
  • Cutaneous use
    • Horse
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM02AC99
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • C.P.M. ContractPharma GmbH
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2832 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
Average: 1 (3 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."